Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

202 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Identification of differentially expressed genes from ovarian cancer cells by MICROMAX cDNA microarray system.
Wong KK, Cheng RS, Mok SC. Wong KK, et al. Among authors: mok sc. Biotechniques. 2001 Mar;30(3):670-5. doi: 10.2144/01303dd05. Biotechniques. 2001. PMID: 11252802
Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
Ho SM, Lau KM, Mok SC, Syed V. Ho SM, et al. Among authors: mok sc. Oncogene. 2003 Jul 3;22(27):4243-56. doi: 10.1038/sj.onc.1206437. Oncogene. 2003. PMID: 12833147
Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.
Zorn KK, Jazaeri AA, Awtrey CS, Gardner GJ, Mok SC, Boyd J, Birrer MJ. Zorn KK, et al. Among authors: mok sc. Clin Cancer Res. 2003 Oct 15;9(13):4811-8. Clin Cancer Res. 2003. PMID: 14581352
Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.
Sunde JS, Donninger H, Wu K, Johnson ME, Pestell RG, Rose GS, Mok SC, Brady J, Bonome T, Birrer MJ. Sunde JS, et al. Among authors: mok sc. Cancer Res. 2006 Sep 1;66(17):8404-12. doi: 10.1158/0008-5472.CAN-06-0683. Cancer Res. 2006. PMID: 16951150
Relationship of XIST expression and responses of ovarian cancer to chemotherapy.
Huang KC, Rao PH, Lau CC, Heard E, Ng SK, Brown C, Mok SC, Berkowitz RS, Ng SW. Huang KC, et al. Among authors: mok sc. Mol Cancer Ther. 2002 Aug;1(10):769-76. Mol Cancer Ther. 2002. PMID: 12492109
Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.
Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Schorge JO, et al. Among authors: mok sc. Clin Cancer Res. 2004 May 15;10(10):3474-8. doi: 10.1158/1078-0432.CCR-03-0365. Clin Cancer Res. 2004. PMID: 15161704
Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
Huddleston HG, Wong KK, Welch WR, Berkowitz RS, Mok SC. Huddleston HG, et al. Among authors: mok sc. Gynecol Oncol. 2005 Jan;96(1):77-83. doi: 10.1016/j.ygyno.2004.08.047. Gynecol Oncol. 2005. PMID: 15589584
Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
Ghosh S, Albitar L, LeBaron R, Welch WR, Samimi G, Birrer MJ, Berkowitz RS, Mok SC. Ghosh S, et al. Among authors: mok sc. Gynecol Oncol. 2010 Oct;119(1):114-20. doi: 10.1016/j.ygyno.2010.05.029. Epub 2010 Jul 8. Gynecol Oncol. 2010. PMID: 20619446 Free PMC article.
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.
Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, Birrer MJ. Vathipadiekal V, et al. Among authors: mok sc. PLoS One. 2012;7(1):e29079. doi: 10.1371/journal.pone.0029079. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272227 Free PMC article.
New technologies for the identification of markers for early detection of ovarian cancer.
Bandera CA, Ye B, Mok SC. Bandera CA, et al. Among authors: mok sc. Curr Opin Obstet Gynecol. 2003 Feb;15(1):51-5. doi: 10.1097/00001703-200302000-00008. Curr Opin Obstet Gynecol. 2003. PMID: 12544502 Review.
202 results
Jump to page